BB Biotech’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-68,156
| Closed | -$25.5M | – | 36 |
|
|
2018
Q4 | $25.5M | Sell |
68,156
-131,844
| -66% | -$49.2M | 0.82% | 27 |
|
|
2018
Q3 | $80.8M | Sell |
200,000
-70,000
| -26% | -$28.3M | 2.14% | 17 |
|
|
2018
Q2 | $93.1M | Sell |
270,000
-10,000
| -4% | -$3.45M | 2.69% | 15 |
|
|
2018
Q1 | $96.4M | Buy |
280,000
+75,000
| +37% | +$25.8M | 2.66% | 14 |
|
|
2017
Q4 | $77.1M | Hold |
205,000
| – | – | 2.17% | 16 |
|
|
2017
Q3 | $91.7M | Buy |
205,000
+25,000
| +14% | +$11.2M | 2.54% | 15 |
|
|
2017
Q2 | $88.4M | Sell |
180,000
-65,000
| -27% | -$31.9M | 2.7% | 13 |
|
|
2017
Q1 | $94.9M | Hold |
245,000
| – | – | 3.11% | 12 |
|
|
2016
Q4 | $89.9M | Hold |
245,000
| – | – | 3.33% | 11 |
|
|
2016
Q3 | $98.5M | Buy |
245,000
+40,000
| +20% | +$16.1M | 3.46% | 10 |
|
|
2016
Q2 | $71.6M | Hold |
205,000
| – | – | 2.83% | 12 |
|
|
2016
Q1 | $73.9M | Hold |
205,000
| – | – | 2.94% | 12 |
|
|
2015
Q4 | $111M | Hold |
205,000
| – | – | 3.13% | 12 |
|
|
2015
Q3 | $95.4M | Buy |
205,000
+7,000
| +4% | +$3.26M | 3.02% | 11 |
|
|
2015
Q2 | $101M | Hold |
198,000
| – | – | 2.74% | 14 |
|
|
2015
Q1 | $89.4M | Hold |
198,000
| – | – | 2.66% | 15 |
|
|
2014
Q4 | $81.2M | Sell |
198,000
-35,000
| -15% | -$14.4M | 2.63% | 13 |
|
|
2014
Q3 | $84M | Hold |
233,000
| – | – | 3.42% | 11 |
|
|
2014
Q2 | $65.8M | Buy |
233,000
+10,000
| +4% | +$2.82M | 3.13% | 9 |
|
|
2014
Q1 | $67M | Buy |
223,000
+31,000
| +16% | +$9.31M | 3.45% | 10 |
|
|
2013
Q4 | $52.8M | Buy |
192,000
+90,000
| +88% | +$24.8M | 2.82% | 11 |
|
|
2013
Q3 | $31.9M | Buy |
+102,000
| New | +$31.9M | 1.74% | 15 |
|